Drug therapy for stable angina pectoris
TA Rousan, ST Mathew, U Thadani - Drugs, 2017 - Springer
Chronic stable angina pectoris refers to the predictable, reproducible occurrence of pressure
or a choking sensation in the chest or adjacent areas caused by myocardial ischemia in …
or a choking sensation in the chest or adjacent areas caused by myocardial ischemia in …
[HTML][HTML] Probing the interactions of 31 mycotoxins with xanthine oxidase: alternariol, alternariol-3-sulfate, and α-zearalenol are allosteric inhibitors of the enzyme
Mycotoxins are frequent toxic contaminants in foods and beverages, causing a significant
health threat. Interactions of mycotoxins with biotransformation enzymes (eg, cytochrome …
health threat. Interactions of mycotoxins with biotransformation enzymes (eg, cytochrome …
[HTML][HTML] Stable angina medical therapy management guidelines: a critical review of guidelines from the European Society of Cardiology and National Institute for …
TA Rousan, U Thadani - European Cardiology Review, 2019 - ncbi.nlm.nih.gov
Most patients with stable angina can be managed with lifestyle changes, especially smoking
cessation and regular exercise, along with taking antianginal drugs. Randomised controlled …
cessation and regular exercise, along with taking antianginal drugs. Randomised controlled …
Anti‐nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors
AP Schmidt, AE Böhmer, C Antunes… - British journal of …, 2009 - Wiley Online Library
Background and purpose: Allopurinol is a potent inhibitor of the enzyme xanthine oxidase,
used primarily in the treatment of hyperuricemia and gout. It is well known that purines exert …
used primarily in the treatment of hyperuricemia and gout. It is well known that purines exert …
[HTML][HTML] Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of …
Background Perinatal asphyxia and resulting hypoxic-ischemic encephalopathy is a major
cause of death and long-term disability in term born neonates. Up to 20,000 infants each …
cause of death and long-term disability in term born neonates. Up to 20,000 infants each …
Predicting allopurinol response in patients with gout
Aims The primary aim of this research was to predict the allopurinol maintenance doses
required to achieve the target plasma urate of≤ 0.36 mmol l− 1. Methods A population …
required to achieve the target plasma urate of≤ 0.36 mmol l− 1. Methods A population …
Oxypurinol–a novel marker for wastewater contamination of the aquatic environment
J Funke, C Prasse, CL Eversloh, TA Ternes - Water research, 2015 - Elsevier
The anti-gout agent allopurinol is one of the most prescribed pharmaceuticals in Germany
and is widely metabolized into oxypurinol (80%) as well as the corresponding riboside …
and is widely metabolized into oxypurinol (80%) as well as the corresponding riboside …
[HTML][HTML] Low-dose azathioprine in combination with allopurinol: the past, present and future of this useful duo
AK Turbayne, MP Sparrow - Digestive Diseases and Sciences, 2022 - Springer
The inflammatory bowel diseases (IBD) are complex immune-mediated inflammatory
diseases that are associated with significant morbidity around the world. As our …
diseases that are associated with significant morbidity around the world. As our …
Allopurinol: old drug, new indication in neonates?
KV Annink, AR Franz, JB Derks… - Current …, 2017 - ingentaconnect.com
Background: Hypoxic-ischemic encephalopathy (HIE) is an important cause of neonatal
mortality and neurological morbidity, even despite hypothermia treatment. Neuronal damage …
mortality and neurological morbidity, even despite hypothermia treatment. Neuronal damage …
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout
Objective. To investigate the pharmacokinetic and pharmacodynamic interaction between
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …
probenecid and oxypurinol (the active metabolite of allopurinol) in patients with gout …